218
Views
1
CrossRef citations to date
0
Altmetric
Review

Eosinophilic esophagitis: does age matter?

ORCID Icon, , , , , , , & show all
Pages 211-223 | Received 22 Jul 2023, Accepted 20 Oct 2023, Published online: 07 Nov 2023

References

  • Muir A, Falk GW. Eosinophilic Esophagitis: A Review. JAMA. 2021;326:1310–1318. doi: 10.1001/jama.2021.14920
  • Bredenoord AJ, Patel K, Schoepfer AM, et al. Disease Burden and Unmet Need in Eosinophilic Esophagitis. Am J Gastroenterol. 2022;117(8):1231–1241. doi: 10.14309/ajg.0000000000001777
  • Dellon ES, Hirano I. Epidemiology and Natural History of Eosinophilic Esophagitis. Gastroenterology. 2018;154(2):319–32.e3. doi: 10.1053/j.gastro.2017.06.067
  • Furuta GT, Katzka DA, Ingelfinger JR. Eosinophilic Esophagitis. N Engl J Med. 2015;373(17):1640–1648. doi: 10.1056/NEJMra1502863
  • Hahn JW, Lee K, Shin JI, et al. Global Incidence and Prevalence of Eosinophilic Esophagitis, 1976-2022: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2023. doi:10.1016/j.cgh.2023.06.005
  • Shah MZ, Polk BI. Eosinophilic Esophagitis: The Role of Environmental Exposures. Immunol Allergy Clin North Am. 2022;42(4):761–770. doi: 10.1016/j.iac.2022.05.006
  • Dellon ES, Gonsalves N, Abonia JP, et al. International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature. Clin Gastroenterol Hepatol. 2022;20(11):2474–84.e3. doi: 10.1016/j.cgh.2022.02.017
  • Pesek RD, Reed CC, Muir AB, et al. Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter Consortium. Am J Gastroenterol. 2019;114(6):984–994. doi: 10.14309/ajg.0000000000000228
  • Dellon ES, Gibbs WB, Fritchie KJ, et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009;7(12):1305–1313. quiz 261. doi: 10.1016/j.cgh.2009.08.030
  • Straumann A, Spichtin HP, Grize L, et al. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology. 2003;125(6):1660–1669. doi: 10.1053/j.gastro.2003.09.024
  • Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128(1):3-20.e6; quiz 1–2. doi: 10.1016/j.jaci.2011.02.040
  • Vernon N, Shah S, Lehman E, et al. Comparison of atopic features between children and adults with eosinophilic esophagitis. Allergy asthma proc. 2014;35(5):409–414. doi: 10.2500/aap.2014.35.3768
  • Dhar A, Haboubi HN, Attwood SE, et al. British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults. Gut. 2022;71:1459–1487. doi: 10.1136/gutjnl-2022-327326
  • Lucendo AJ, Molina-Infante J. Dietary therapy for eosinophilic esophagitis: chances and limitations in the clinical practice. Expert Rev Gastroenterol Hepatol. 2020;14(10):941–952. doi: 10.1080/17474124.2020.1791084
  • Votto M, De Filippo M, Lenti MV, et al. Diet Therapy in Eosinophilic Esophagitis. Focus on a Personalized Approach. Front Pediatr. 2021;9:820192. doi: 10.3389/fped.2021.820192
  • Sauer BG, Barnes B, McGowan EC. Strategies for the use of Dupilumab in Eosinophilic Esophagitis. Am J Gastroenterol. 2023;118(5):780–783. doi: 10.14309/ajg.0000000000002206
  • Attwood SE, Smyrk TC, Demeester TR, et al. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci. 1993;38(1):109–116. doi: 10.1007/bf01296781
  • Straumann A, Spichtin HP, Bernoulli R, et al. Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings. Schweiz Med Wochenschr. 1994;124(33):1419–1429.
  • Navarro P, Arias Á, Arias-González L, et al. Systematic review with meta-analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies. Aliment Pharmacol Ther. 2019;49(9):1116–1125. doi: 10.1111/apt.15231
  • Biedermann L, Straumann A, Greuter T, et al. Eosinophilic esophagitis—established facts and new horizons. Semin Immunopathol. 2021;43(3):319–335. doi:10.1007/s00281-021-00855-y
  • Biedermann L, Straumann A. Mechanisms and clinical management of eosinophilic oesophagitis: an overview. Nat Rev Gastroenterol Hepatol. 2023;20:101–119. doi: 10.1038/s41575-022-00691-x
  • Giriens B, Yan P, Safroneeva E, Zwahlen M, Reinhard A, Nydegger A, Vavricka S, Sempoux C, Straumann A and Schoepfer A M. (2015). Escalating incidence of eosinophilic esophagitis in C anton of V aud, S witzerland, 1993–2013: a population-based study. Allergy, 70(12), 1633–1639. 10.1111/all.12733 1633–1639
  • Votto M, De Filippo M, Caminiti L, et al. Eosinophilic gastrointestinal disorders and allergen immunotherapy: Lights and shadows. Pediatr Allergy Immunol. 2021;32(5):814–823. doi: 10.1111/pai.13458
  • Arias A, González-Cervera J, Tenias JM, et al. Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. Gastroenterology. 2014;146(7):1639–1648. doi: 10.1053/j.gastro.2014.02.006
  • Xue Z, Miller TL, Abramson L, et al. Association of eosinophilic esophagitis with autoimmune and connective tissue disorders, and the impact on treatment response. Dis Esophagus. 2022;36(1). doi: 10.1093/dote/doac043
  • Verzegnassi F, Bua J, De Angelis P, et al. Eosinophilic oesophagitis and coeliac disease: is it just a casual association?. Gut. England. 2007;56(7):1029–1030. doi: 10.1136/gut.2006.117986
  • Quaglietta L, Coccorullo P, Miele E, et al. Eosinophilic oesophagitis and coeliac disease: is there an association?. Aliment Pharmacol Ther. 2007;26(3):487–493. doi: 10.1111/j.1365-2036.2007.03388.x
  • Cristofori F, D’Abramo FS, Rutigliano V, et al. Esophageal Eosinophilia and Eosinophilic Esophagitis in Celiac Children: A Ten Year Prospective Observational Study. Nutrients. 2021;13(11):3755. doi: 10.3390/nu13113755
  • Dellon ES, Kim HP, Sperry SL, et al. A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. Gastrointest Endosc. 2014;79(4):577–85.e4. doi: 10.1016/j.gie.2013.10.027
  • Chehade M, Jones SM, Pesek RD, et al. Phenotypic Characterization of Eosinophilic Esophagitis in a Large Multicenter Patient Population from the Consortium for Food Allergy Research. J Allergy Clin Immunol Pract. 2018;6(5):1534–44.e5. doi: 10.1016/j.jaip.2018.05.038
  • Schoepfer AM, Safroneeva E, Bussmann C, et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology. 2013;145(6):1230-6.e1–2. doi: 10.1053/j.gastro.2013.08.015
  • Lipka S, Kumar A, Richter JE. Impact of Diagnostic Delay and Other Risk Factors on Eosinophilic Esophagitis Phenotype and Esophageal Diameter. J Clin Gastroenterol. 2016;50(2):134–140. doi: 10.1097/mcg.0000000000000297
  • Warners MJ, Oude Nijhuis RAB, de Wijkerslooth LRH, et al. The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort. Am J Gastroenterol. 2018;113(6):836–844. doi: 10.1038/s41395-018-0052-5
  • Dunn JLM, Shoda T, Caldwell JM, et al. Esophageal type 2 cytokine expression heterogeneity in eosinophilic esophagitis in a multisite cohort. J Allergy Clin Immunol. 2020;145(6):1629–40.e4. doi: 10.1016/j.jaci.2020.01.051
  • Singla MB, Chehade M, Brizuela D, et al. Early Comparison of Inflammatory vs. Fibrostenotic Phenotype in Eosinophilic Esophagitis in a Multicenter Longitudinal Study. Clin Transl Gastroenterol. 2015;6(12):e132. doi: 10.1038/ctg.2015.62
  • Munoz-Persy M, Lucendo AJ. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach. Eur J Pediatr. 2018;177(5):649–663. doi: 10.1007/s00431-018-3129-7
  • O’Shea KM, Aceves SS, Dellon ES, et al. Pathophysiology of Eosinophilic Esophagitis. Gastroenterology. 2018;154(2):333–345. doi: 10.1053/j.gastro.2017.06.065
  • Lucendo AJ, Santander C, Savarino E, et al. EoE CONNECT, the European Registry of Clinical, Environmental, and Genetic Determinants in Eosinophilic Esophagitis: rationale, design, and study protocol of a large-scale epidemiological study in Europe. Therap Adv Gastroenterol. 2022;15:17562848221074204. doi: 10.1177/17562848221074204
  • Alexander ES, Martin LJ, Collins MH, et al. Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis. J Allergy Clin Immunol. 2014;134(5):1084–92.e1. doi: 10.1016/j.jaci.2014.07.021
  • Rothenberg ME, Spergel JM, Sherrill JD, et al. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet. 2010;42(4):289–291. doi: 10.1038/ng.547
  • Sleiman PM, Wang ML, Cianferoni A, et al. GWAS identifies four novel eosinophilic esophagitis loci. Nat Commun. 2014;5(1):5593. doi: 10.1038/ncomms6593
  • Sherrill JD, Rothenberg ME. Genetic and epigenetic underpinnings of eosinophilic esophagitis. Gastroenterol Clin North Am. 2014;43(2):269–280. doi: 10.1016/j.gtc.2014.02.003
  • Kottyan LC, Parameswaran S, Weirauch MT, et al. The genetic etiology of eosinophilic esophagitis. J Allergy Clin Immunol. 2020;145(1):9–15. doi: 10.1016/j.jaci.2019.11.013
  • Levine J, Lai J, Edelman M, et al. Conservative long-term treatment of children with eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2012;108(5):363–366. doi: 10.1016/j.anai.2012.02.024
  • Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med. United States. 2004;351(9):940–941. doi: 10.1056/NEJM200408263510924
  • Menard-Katcher C, Furuta GT, Kramer RE. Dilation of Pediatric Eosinophilic Esophagitis: Adverse Events and Short-term Outcomes. J Pediatr Gastroenterol Nutr. 2017;64(5):701–706. doi: 10.1097/mpg.0000000000001336
  • Eluri S, Perjar I, Betancourt R, et al. Heartburn and dyspepsia symptom severity improves after treatment and correlates with histology in adults with eosinophilic esophagitis. Dis Esophagus. 2019;32(9):32. doi: 10.1093/dote/doz028
  • Straumann A, Katzka DA. Diagnosis and Treatment of Eosinophilic Esophagitis. Gastroenterology. 2018;154(2):346–359. doi: 10.1053/j.gastro.2017.05.066
  • Rank MA, Sharaf RN, Furuta GT, et al. Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters. Gastroenterology. 2020;158(6):1789–810.e15. doi: 10.1053/j.gastro.2020.02.039
  • Holbreich M, Straumann A. Features of food-induced immediate response in the esophagus (FIRE) in a series of adult patients with eosinophilic esophagitis. Allergy. 2021;76(9):2893–2895. doi: 10.1111/all.14886
  • Biedermann L, Holbreich M, Atkins D, et al. Food-induced immediate response of the esophagus—A newly identified syndrome in patients with eosinophilic esophagitis. Allergy. 2021;76(1):339–347. doi: 10.1111/all.14495
  • Votto M, Naso M, De Filippo M, et al. Food-induced immediate response of the esophagus: A first report in the pediatric age. Allergy. 2022;77(2):711–712. doi: 10.1111/all.15088
  • Visaggi P, Solinas I, Baiano Svizzero F, et al. Non-Invasive and Minimally Invasive Biomarkers for the Management of Eosinophilic Esophagitis beyond Peak Eosinophil Counts: Filling the Gap in Clinical Practice. Diagnostics. 2023;13(17):2806. doi: 10.3390/diagnostics13172806
  • Min SB, Nylund CM, Baker TP, et al. Longitudinal Evaluation of Noninvasive Biomarkers for Eosinophilic Esophagitis. J Clin Gastroenterol. 2017;51(2):127–135. doi: 10.1097/mcg.0000000000000621
  • Josyabhatla R, Abrenica C, Mai T, et al. Plasma Biomarkers and Fractional Exhaled Nitric Oxide in the Diagnosis of Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr. 2023;76(1):59–65. doi: 10.1097/mpg.0000000000003634
  • Alexander JA, Ravi K, Symrk TC, et al. Use of the Esophageal Sponge in Directing Food Reintroduction in Eosinophilic Esophagitis. Clin Gastroenterol Hepatol. 2023;21(2):299–306.e3. doi: 10.1016/j.cgh.2022.05.029
  • Katzka DA, Smyrk TC, Alexander JA, et al. Accuracy and Safety of the Cytosponge for Assessing Histologic Activity in Eosinophilic Esophagitis: A Two-Center Study. Am J Gastroenterol. 2017;112(10):1538–1544. doi: 10.1038/ajg.2017.244
  • Katzka DA, Geno DM, Ravi A, et al. Accuracy, safety, and tolerability of tissue collection by Cytosponge vs endoscopy for evaluation of eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2015;13(1):77–83.e2. doi: 10.1016/j.cgh.2014.06.026
  • Furuta GT, Kagalwalla AF, Lee JJ, et al. The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis. Gut. 2013;62(10):1395–1405. doi: 10.1136/gutjnl-2012-303171
  • Ackerman SJ, Kagalwalla AF, Hirano I, et al. One-Hour Esophageal String Test: A Nonendoscopic Minimally Invasive Test That Accurately Detects Disease Activity in Eosinophilic Esophagitis. Am J Gastroenterol. 2019;114(10):1614–1625. doi: 10.14309/ajg.0000000000000371
  • Hirano I, Moy N, Heckman MG, et al. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013;62(4):489–495. doi: 10.1136/gutjnl-2011-301817
  • Gonsalves N, Policarpio-Nicolas M, Zhang Q, et al. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc. 2006;64(3):313–319. doi: 10.1016/j.gie.2006.04.037
  • Kwiatek MA, Hirano I, Kahrilas PJ, et al. Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology. 2011;140(1):82–90. doi: 10.1053/j.gastro.2010.09.037
  • Nicodème F, Hirano I, Chen J, et al. Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2013;11(9):1101–7.e1. doi: 10.1016/j.cgh.2013.03.020
  • Yadlapati R. Dupilumab: The New Kid on the Block for Management of Eosinophilic Esophagitis. Gastroenterology. 2023;165(1):302–303. doi: 10.1053/j.gastro.2023.02.015
  • Votto M, De Filippo M, Olivero F, et al. Malnutrition in Eosinophilic Gastrointestinal Disorders. Nutrients. 2020;13(1):128. doi: 10.3390/nu13010128
  • Kelly KJ, Lazenby AJ, Rowe PC, et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. 1995;109(5):1503–1512. doi: 10.1016/0016-5085(95)90637-1
  • Kihara Y, Maceyka M, Spiegel S, et al. Lysophospholipid receptor nomenclature review: IUPHAR Review 8. Br J Pharmacol. 2014;171(15):3575–3594. doi: 10.1111/bph.12678
  • Molina-Infante J, Arias Á, Alcedo J, et al. Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: The 2-4-6 study. J Allergy Clin Immunol. 2018;141(4):1365–1372. doi: 10.1016/j.jaci.2017.08.038
  • Steinbach EC, Hernandez M, Dellon ES. Eosinophilic Esophagitis and the Eosinophilic Gastrointestinal Diseases: Approach to Diagnosis and Management. J Allergy Clin Immunol Pract. 2018;6(5):1483–1495. doi: 10.1016/j.jaip.2018.06.012
  • Molina-Infante J, Lucendo AJ. Dietary therapy for eosinophilic esophagitis. J Allergy Clin Immunol. 2018;142(1):41–47. doi: 10.1016/j.jaci.2018.02.028
  • Kliewer K L et al . (2023). One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial. The Lancet Gastroenterology & Hepatology, 8(5), 408–421. 10.1016/S2468-1253(23)00012-2
  • Wechsler JB, Schwartz S, Arva NC, et al. A Single-Food Milk Elimination Diet Is Effective for Treatment of Eosinophilic Esophagitis in Children. Clin Gastroenterol Hepatol. 2022;20(8):1748–56.e11. doi: 10.1016/j.cgh.2021.03.049
  • Dellon ES, Liacouras CA, Molina-Infante J, et al. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology. 2018;155:1022–33.e10. doi:10.1053/j.gastro.2018.07.009
  • Franciosi JP, Mougey EB, Dellon ES, et al. Proton Pump Inhibitor Therapy for Eosinophilic Esophagitis: History, Mechanisms, Efficacy, and Future Directions. J Asthma Allergy. 2022;15:281–302. doi: 10.2147/jaa.s274524
  • Navarro P, Laserna-Mendieta EJ, Guagnozzi D, et al. Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis. Dig Liver Dis. 2021;53(11):1479–1485. doi: 10.1016/j.dld.2021.05.025
  • Lucendo AJ, Á A, Molina-Infante J. Efficacy of Proton Pump Inhibitor Drugs for Inducing Clinical and Histologic Remission in Patients With Symptomatic Esophageal Eosinophilia: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2016;14(1):13–22.e1. doi: 10.1016/j.cgh.2015.07.041
  • Lam AY, Ma C, Lee JK, et al. Eosinophilic esophagitis: New molecules, better life?. Curr Opin Pharmacol. 2022;63:102183. doi: 10.1016/j.coph.2022.102183
  • Rank MA, Sharaf RN, Furuta GT, et al. Technical review on the management of eosinophilic esophagitis: a report from the AGA institute and the joint task force on allergy-immunology practice parameters. Ann Allergy Asthma Immunol. 2020;124(5):424–40.e17. doi: 10.1016/j.anai.2020.03.021
  • Gutiérrez-Junquera C, Fernández-Fernández S, Cilleruelo ML, et al. High Prevalence of Response to Proton-pump Inhibitor Treatment in Children With Esophageal Eosinophilia. J Pediatr Gastroenterol Nutr. 2016;62(5):704–710. doi: 10.1097/mpg.0000000000001019
  • Gutiérrez-Junquera C, Fernández-Fernández S, Cilleruelo ML, et al. Long-term Treatment With Proton Pump Inhibitors Is Effective in Children With Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr. 2018;67(2):210–216. doi: 10.1097/mpg.0000000000001952
  • De Bruyne P, Ito S. Toxicity of long-term use of proton pump inhibitors in children. Arch Dis Child. 2018;103(1):78–82. doi: 10.1136/archdischild-2017-314026
  • Rajan J, Newbury RO, Anilkumar A, et al. Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids. J Allergy Clin Immunol. 2016;137(1):147–56.e8. doi: 10.1016/j.jaci.2015.05.045
  • Straumann A, Conus S, Degen L, et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology. 2010;139(5):1526–37, 37.e1. doi: 10.1053/j.gastro.2010.07.048
  • Dellon ES, Woosley JT, Arrington A, et al. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial. Gastroenterology. 2019;157(1):65–73.e5. doi: 10.1053/j.gastro.2019.03.014
  • Konikoff MR, Noel RJ, Blanchard C, et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology. 2006;131(5):1381–1391. doi: 10.1053/j.gastro.2006.08.033
  • Butz BK, Wen T, Gleich GJ, et al. Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis. Gastroenterology. 2014;147(2):324–33.e5. doi: 10.1053/j.gastro.2014.04.019
  • Schaefer ET, Fitzgerald JF, Molleston JP, et al. Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. Clin Gastroenterol Hepatol. 2008;6(2):165–173. doi: 10.1016/j.cgh.2007.11.008
  • Andreae DA, Hanna MG, Magid MS, et al. Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis. Am J Gastroenterol. 2016;111(8):1187–1197. doi: 10.1038/ajg.2016.238
  • Główczewski A, Krogulska A. Formulations of Topical Steroids in Eosinophilic Esophagitis—Current Treatment and Emerging Possibilities. J Clin Med. 2022;11(5):11. doi: 10.3390/jcm11051454
  • Dellon ES, Sheikh A, Speck O, et al. Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis. Gastroenterology. 2012;143(2):321–4.e1. doi: 10.1053/j.gastro.2012.04.049
  • Miehlke S, Hruz P, Vieth M, et al. A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis. Gut. 2016;65(3):390–399. doi: 10.1136/gutjnl-2014-308815
  • Dohil R, Newbury R, Fox L, et al. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology. 2010;139(2):418–429. doi: 10.1053/j.gastro.2010.05.001
  • Gupta SK, Vitanza JM, Collins MH. Efficacy and safety of oral budesonide suspension in pediatric patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2015;13(1):66–76.e3. doi: 10.1016/j.cgh.2014.05.021
  • Oliva S, Rossetti D, Papoff P, et al. A 12-Week Maintenance Therapy with a New Prepared Viscous Budesonide in Pediatric Eosinophilic Esophagitis. Dig Dis Sci. 2019;64(6):1571–1578. doi: 10.1007/s10620-018-5449-x
  • Straumann A, Lucendo AJ, Miehlke S, et al. Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis. Gastroenterology. 2020;159(5):1672–85.e5. doi: 10.1053/j.gastro.2020.07.039
  • Dellon ES, Gonsalves N, Hirano I, et al. ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108(5):679–92; quiz 93. doi: 10.1038/ajg.2013.71
  • Dellon ES, Katzka DA, Collins MH, et al. Safety and Efficacy of Budesonide Oral Suspension Maintenance Therapy in Patients With Eosinophilic Esophagitis. Clin Gastroenterol Hepatol. 2019;17(4):666–73.e8. doi: 10.1016/j.cgh.2018.05.051
  • Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respir med. 2006;100(8):1307–1317. doi: 10.1016/j.rmed.2005.11.020
  • Hsu S, Wood C, Pan Z, et al. Adrenal Insufficiency in Pediatric Eosinophilic Esophagitis Patients Treated with Swallowed Topical Steroids. Pediatr Allergy Immunol Pulmonol. 2017;30(3):135–140. doi: 10.1089/ped.2017.0779
  • Syverson EP, Hait E, McDonald DR, et al. Oral viscous mometasone is an effective treatment for eosinophilic esophagitis. J Allergy Clin Immunol Pract. 2020;8(3):1107–1109. doi: 10.1016/j.jaip.2019.08.042
  • Schroeder S, Fleischer DM, Masterson JC, et al. Successful treatment of eosinophilic esophagitis with ciclesonide. J Allergy Clin Immunol. United States. 2012;129(5):1419–1421. doi: 10.1016/j.jaci.2012.03.007
  • Dellon ES, Rothenberg ME, Collins MH, et al. Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis. N Engl J Med. 2022;387(25):2317–2330. doi: 10.1056/NEJMoa2205982
  • Beppu LY, Anilkumar AA, Newbury RO, et al. TGF-β1–induced phospholamban expression alters esophageal smooth muscle cell contraction in patients with eosinophilic esophagitis. J Allergy Clin Immunol. 2014;134(5):1100–7.e4. doi: 10.1016/j.jaci.2014.04.004
  • Moawad FJ, Molina-Infante J, Lucendo AJ, et al. Systematic review with meta-analysis: endoscopic dilation is highly effective and safe in children and adults with eosinophilic oesophagitis. Aliment Pharmacol Ther. 2017;46(2):96–105. doi: 10.1111/apt.14123
  • Dougherty M, Runge TM, Eluri S, et al. Esophageal dilation with either bougie or balloon technique as a treatment for eosinophilic esophagitis: a systematic review and meta-analysis. Gastrointest Endosc. 2017;86(4):581–91.e3. doi: 10.1016/j.gie.2017.04.028
  • Runge TM, Eluri S, Woosley JT, et al. Control of inflammation decreases the need for subsequent esophageal dilation in patients with eosinophilic esophagitis. Dis Esophagus. 2017;30(7):1–7. doi: 10.1093/dote/dox042
  • Aceves SS, Alexander JA, Baron TH, et al. Endoscopic approach to eosinophilic esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference. Gastrointest Endosc. 2022;96:576–92.e1. doi:10.1016/j.gie.2022.05.013
  • Schoepfer AM, Henchoz S, Biedermann L, et al. Technical feasibility, clinical effectiveness, and safety of esophageal stricture dilation using a novel endoscopic attachment cap in adults with eosinophilic esophagitis. Gastrointest Endosc. 2021;94(5):912–9.e2. doi: 10.1016/j.gie.2021.05.017
  • Schoepfer AM, Gonsalves N, Bussmann C, et al. Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation. Am J Gastroenterol. 2010;105(5):1062–1070. doi: 10.1038/ajg.2009.657
  • Furuta GT. Eosinophilic esophagitis in children and adults. Gastroenterol Hepatol. 2008;4:775–777. (N Y).
  • Votto M, Lenti MV, De Silvestri A, et al. Evaluation of diagnostic time in pediatric patients with eosinophilic gastrointestinal disorders according to their clinical features. Ital J Pediatr. 2023;49(1):9. England © 2023. The Author(s). doi: 10.1186/s13052-023-01410-1
  • Arnim UV, Biedermann L, Aceves SS, et al. Monitoring Patients With Eosinophilic Esophagitis in Routine Clinical Practice - International Expert Recommendations. Clin Gastroenterol Hepatol. 2022;21(10):2526–2533. doi: 10.1016/j.cgh.2022.12.018
  • van Rhijn BD, Verheij J, Smout AJ, et al. The Endoscopic Reference Score shows modest accuracy to predict histologic remission in adult patients with eosinophilic esophagitis. Neurogastroenterol Motil. 2016;28(11):1714–1722. doi: 10.1111/nmo.12872

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.